Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ctt Pharmaceutical Hlds Inc (CTTH)

Ctt Pharmaceutical Hlds Inc (CTTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTTH with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0140 +51.43%
on 02/26/24
0.0300 -29.33%
on 03/13/24
+0.0033 (+18.44%)
since 02/16/24
3-Month
0.0100 +112.00%
on 02/06/24
0.0392 -45.92%
on 01/04/24
unch (unch)
since 12/18/23
52-Week
0.0030 +606.67%
on 08/28/23
0.1000 -78.80%
on 10/27/23
-0.0008 (-3.64%)
since 03/17/23

Most Recent Stories

More News
CTT Pharmaceuticals Existing Canadian Patent Confirmed to Include Psychedelic Applications

Company Advancing Licensing and Partnership Negotiations Patent Applications Accepted in Australia and Jamaica - Grants Anticipated Shortly HAMILTON, ON / ACCESSWIRE / June 15, 2021 / CTT Pharmaceutical...

CTTH : 0.0212 (-14.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.0285
2nd Resistance Point 0.0271
1st Resistance Point 0.0241
Last Price 0.0212
1st Support Level 0.0197
2nd Support Level 0.0183
3rd Support Level 0.0153

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0629
Fibonacci 50% 0.0515
Fibonacci 38.2% 0.0401
Last Price 0.0212
52-Week Low 0.0030

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar